NervGen Pharma Corp.
NGENF
$4.41
$0.184.26%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -29.01% | 14.15% | -16.11% | -22.83% | -19.87% |
| Total Receivables | 138.98% | -60.77% | -18.84% | 7,320.83% | -42.86% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 72.19% | -0.53% | -26.68% | 4.91% | -27.52% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 27.26% | 52.71% | -65.09% | 28.72% | 45.41% |
| Total Current Assets | -24.84% | 12.91% | -18.98% | -18.65% | -18.67% |
|
|
|||||
| Total Current Assets | -24.84% | 12.91% | -18.98% | -18.65% | -18.67% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -26.32% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -5.21% | 2.14% | -2.88% | -8.86% | -1.56% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -76.42% | -41.71% |
| Total Assets | -24.34% | 12.61% | -18.63% | -18.53% | -18.42% |
|
|
|||||
| Total Accounts Payable | -- | 7.09% | -- | -- | -17.20% |
| Total Accrued Expenses | 2.15% | 22.38% | -9.59% | 58.11% | -6.15% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -43.50% | -25.66% | -15.83% | -4.65% | 2.75% |
| Total Finance Division Other Current Liabilities | -17.54% | 34.20% | -16.74% | 14.12% | -14.17% |
| Total Other Current Liabilities | -17.54% | 34.20% | -16.74% | 14.12% | -14.17% |
| Total Current Liabilities | -12.09% | 30.13% | -14.42% | 19.79% | -12.52% |
|
|
|||||
| Total Current Liabilities | -12.09% | 30.13% | -14.42% | 19.79% | -12.52% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -76.42% | -41.71% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -12.09% | 30.13% | -14.46% | 19.55% | -12.63% |
|
|
|||||
| Common Stock & APIC | 0.20% | 13.07% | 1.72% | -5.41% | 1.89% |
| Retained Earnings | -1.86% | -14.43% | -3.97% | -2.53% | -7.30% |
| Treasury Stock & Other | 0.02% | 8.71% | 6.24% | -0.17% | 8.43% |
| Total Common Equity | -213.62% | -169.66% | -46.02% | -73.64% | -25.55% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -213.62% | -169.66% | -46.02% | -73.64% | -25.55% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -213.62% | -169.66% | -46.02% | -73.64% | -25.55% |
|
|
|||||